Cortical Electrophysiology of Response Inhibition in Parkinson's Disease
Recruiting
Phase 4
Interventional Study
Parkinson Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 45 – 75
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Basic Science
- Participants needed
- 80 (estimated)
- Sponsor
- Emory University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Patients with Parkinson's Disease will be studied before, during, and after a deep brain stimulation implantation procedure to see if the stimulation location and the size of the electrical field produced by subthalamic nucleus (STN) DBS determine the degree to which DBS engages circuits that involve prefrontal cortex executive functions, and therefore have a direct impact on the patient's ability…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria for Persons with Parkinson's Disease for Aim 1:
* diagnosis of idiopathic Parkinson's disease (PD)
* Hoehn and Yahr (H\&Y) stage 2-4 (off medication)
Exclusion Criteria for Persons with Parkinson's Disease for Aim 1:
* severe tremor at rest or severe dyskinesia which would caus…
Contacts
Svjetlana Miocinovic, MD, PhD
404-712-9065
CONTACT